BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yu J, Ma S, Tian S, Zhang M, Ding X, Liu Y, Yang F, Hu Y, Xuan G, Zhou X, Wang J, Han Y. Systematic Construction and Validation of a Prognostic Model for Hepatocellular Carcinoma Based on Immune-Related Genes. Front Cell Dev Biol 2021;9:700553. [PMID: 34671598 DOI: 10.3389/fcell.2021.700553] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Luo H, Jiang Q, Luo Y, Yang M, Yu Y, Yu C, Wang X. Comprehensive analysis of ESR1-related ceRNA axis as a novel prognostic biomarker in hepatocellular carcinoma. Epigenomics 2023. [PMID: 36695093 DOI: 10.2217/epi-2022-0291] [Reference Citation Analysis]
2 Huang Y, Zou Y, Tian Y, Yang Z, Hou Z, Li P, Liu F, Ling J, Wen Y. N6-methylandenosine-related immune genes correlate with prognosis and immune landscapes in gastric cancer. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1009881] [Reference Citation Analysis]
3 Xu L, Yang H, Yan M, Li W. Matrix metalloproteinase 1 is a poor prognostic biomarker for patients with hepatocellular carcinoma. Clin Exp Med 2022. [PMID: 36169759 DOI: 10.1007/s10238-022-00897-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]